Company Research Report: Compremium AG

Company Overview

• Name: Compremium AG

• Mission: Dedicated to meeting unmet needs in the practice of medicine and improving patient diagnostics.

• Founded: 2011

• Founder: Dr. med. Ulrich Baumann

• Key People:

• Vincent Baumann - Chief Executive Officer

• Ulrich Baumann, MD - Chief Medical Officer

• Francois Monory - OPEX-Advisor & Board Member

• Aswin Bhuvanendran - Chief Commercial Officer

• Patrick Roth - Chief Operations Officer

• Robin Demesmaeker - Chief Technology Officer

• Craig Sisson - Medical Advisor

• Peter Frei, MBE - IP Manager

• Charlotte Moerman - Clinical Affairs Manager

• Simone Troxler - Head of Medical Affairs

• Federico Milani - Head of Software Development

• Yan Pellouchoud - Chief Procurement Officer

• André Steiner - Head of Sales

• Karin Roth - Communication

• Cordelia Trümpy - Marketing & Communication

• Jurjen Zoethout - Regulatory Advisor

• Headquarters: Muri b. Bern, Switzerland

• Number of Employees: No information is available

• Revenue: No information is available

• What the Company is Known For: Developing innovative, non-invasive diagnostic tools for pressure-related medical conditions, focusing on critical pressure physiologies such as venous, intracranial, intramuscular, and intratumoral pressures.

Products

CPMX1

• Description: A diagnostic system providing a quantitative and intuitive method for diagnosing musculoskeletal conditions.

• Key Features:

• FDA Cleared

• Non-invasive measurement with an excellent correlation with intra-compartmental pressure

• Excellent sensitivity and specificity in diagnosing acute compartment syndrome.

CPMX2

• Description: A system designed to directly measure pressure in veins for diagnosing vascular conditions.

• Key Features:

• For investigational purposes only

• Focuses on measuring occlusion pressure in the venous system.

Product Features

• Compressibility: Measures the relative change in compartment depth under external pressure.

• Occlusion Pressure: Assesses pressure at vessel occlusion points.

• Additional Features (under development for investigational use only):

• AI-enabled for ease and consistency of use

• EHR connected for seamless integration into clinical workflows

• Telemedicine enabled for remote diagnostics

• Long-lasting battery life and touchscreen interface

Recent Developments

• Certifications and Recognitions:

• Achieved ISO 13485:2016 certification for quality management systems, underscoring the company's commitment to maintaining high standards in medical device design and development.

• CPMX1 is now MIL-STD 810H compliant, signifying its robustness for use in challenging environments, particularly by military combat medics.

• Clinical Advancements:

• Conducted a pivotal clinical study on the non-invasive method for diagnosing Acute Compartment Syndrome in pediatric patients, potentially eliminating the need for invasive measurement techniques.

• Partnerships and Collaborations:

• Established clinical partnerships with several institutions including Maxima Medisch Center, Charité - Universitätsmedizin Berlin, and collaboration with the Schulthess Klinik in Zurich.

Conclusion

The information provided highlights Compremium AG's commitment to pioneering non-invasive diagnostic solutions tailored to meet critical unmet needs in healthcare. Their recent certifications and ongoing research signify a robust potential for breakthrough innovations in the medical device industry tailored to practical applications and patient outcomes.